Maximising the diagnostic potential of APTT-based screening assays for activated protein C resistance.

about

Maximising the diagnostic potential of APTT-based screening assays for activated protein C resistance.

Item

http://www.wikidata.org/entity/Q53374353

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Maximising the diagnostic pote ...... ctivated protein C resistance.

@en

Maximising the diagnostic pote ...... ctivated protein C resistance.

@nl

type

Item

label

Maximising the diagnostic pote ...... ctivated protein C resistance.

@en

Maximising the diagnostic pote ...... ctivated protein C resistance.

@nl

prefLabel

Maximising the diagnostic pote ...... ctivated protein C resistance.

@en

Maximising the diagnostic pote ...... ctivated protein C resistance.

@nl

P1476

Maximising the diagnostic pote ...... ctivated protein C resistance.

@en

P2093

A P Culhane

http://www.w3.org/2001/XMLSchema#string

B J Hunt

http://www.w3.org/2001/XMLSchema#string

E Chege

http://www.w3.org/2001/XMLSchema#string

G W Moore

http://www.w3.org/2001/XMLSchema#string

P2860

Congenital and acquired activated protein C resistance

Clinical guidelines for testing for heritable thrombophilia.

The phenomenon known as acquired activated protein C resistance.

Inherited antithrombin deficiency: a review.

Acquired activated protein C resistance, thrombophilia and adverse pregnancy outcomes: a study performed in an Irish cohort of pregnant women

Combining Taipan snake venom time/Ecarin time screening with the mixing studies of conventional assays increases detection rates of lupus anticoagulants in orally anticoagulated patients.

Quality assurance issues and interpretation of assays.

APC resistance: biological basis and acquired influences.

The phenotypic and genetic assessment of protein C deficiency.

Assessment of the impact of rivaroxaban on coagulation assays: laboratory recommendations for the monitoring of rivaroxaban and review of the literature.

P304

844-852

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/IJLH.12419

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26303324

http://www.w3.org/2001/XMLSchema#string